Altered red blood cell e antigen expression in variant RHCE*ce alleles. Is it worth doing a molecular analysis?

Similar documents
THINKING OUTSIDE THE (GATA) BOX GINA FOLK, MLS(ASCP) CM SBB CM

Case Study: Jackie Ensley, MLS(ASCP) CM SBB CM. Immunohematology Reference Laboratory Manager Kentucky Blood Center

Antibodies Are Not Always What They Seem. Lindsay Peters MLS(ASCP)SBB Reference Laboratory Supervisor Mississippi Valley Regional Blood Center

Lynsi Rahorst, MT(ASCP) IRL Staff Technologist II. Everything But the Kitchen Sink!

4/5/2018. Duffy A? Duffy B? Duffy Three?! Panel Work-up 8. What is Fy3? Panel Work-up continued. The Duffy System. What is Fy3?

Case Studies. Nancy Mullis, MT(ASCP)SBB American Red Cross IRL SEABB 2011

Immunohematology Case Study

Resolving immunohematology Case Studies

IgG blocking: An alternative red cell treatment method for phenotyping

Future Webinars. Future Webinars

Continuing Education Webinar Series

BIOLOGY 101. CHAPTER 17: Gene Expression: From Gene to Protein. The Flow of Genetic Information

HDN ABID CASE # 4 Case study by Jim Perkins, M.D. ( 2010)

Troubleshooting the Problem Patient

Turing Machines. Human-aware Robotics. 2017/10/17 & 19 Chapter 3.2 & 3.3 in Sipser Ø Announcement:

INDIAN IMMUNOHEMATOLOGY INITIATIVE CASE OF THE MONTH: May 2008 Case Study by Jan Hamilton MT(ASCP)SBB ( 2009)

NUMBERS, MATHEMATICS AND EQUATIONS

Evolution. Diversity of Life. Lamarck s idea is called the. If a body

CHAPTER 2 Algebraic Expressions and Fundamental Operations

CAUSAL INFERENCE. Technical Track Session I. Phillippe Leite. The World Bank

Forensic Science: Fundamentals & Investigations, 2e Chapter 6. All rights Reserved Cengage/NGL/South-Western 2016

Writing Guidelines. (Updated: November 25, 2009) Forwards

Advanced Antibody Identification: Case Studies. Justin R. Rhees, M.S., MLS(ASCP) CM, SBB CM University of Utah Department of Pathology

Chapter 6 Fingerprints

SUPPLEMENTARY MATERIAL GaGa: a simple and flexible hierarchical model for microarray data analysis

Introduction to Immunohematology. W. John Judd, FIBMS, MIBiol Emeritus Professor University of Michigan

HEMOLYSIS AFTER CHEMOTHERAPY Case Study by Jim Perkins M.D. and Leon Dragon M.D. ( 2010)

MODULE FOUR. This module addresses functions. SC Academic Elementary Algebra Standards:

A NEW PANAGGLUTININ IN A TRANSFUSION-DEPENDENT PATIENT A Case Study by Jim Perkins, M.D. ( 2009)

Antibody Identification I

Guide to Using the Rubric to Score the Klf4 PREBUILD Model for Science Olympiad National Competitions

(without reference to ABO and Rh)

ANNUAL REPORT SUMMARY FOR TESTING IN Prepared by the Relationship Testing Program Unit

To take the slides out of full screen mode and display the Acrobat Reader controls, simply hit the Esc key on your computer keyboard.

Biocomputers. [edit]scientific Background

1/31/2017. Advanced Transfusion Case Studies

Antibody Identification. Case Studies

CHAPTER 24: INFERENCE IN REGRESSION. Chapter 24: Make inferences about the population from which the sample data came.

800 Adenine Guanine. Gate Voltage (V)

Chapter 1 Notes Using Geography Skills

7. Medical Applications of Molecular Biotechnology

ERYTHROBLASTOSIS FETALIS WITHOUT AN OBVIOUS CAUSE Case Study by Jim Perkins, MD ( 2010)

5.60 Thermodynamics & Kinetics Spring 2008

Associated Students Flacks Internship

Pollen and Spore Examination By the end of this chapter you will be able to:

Hypothesis Tests for One Population Mean

AMERICAN PETROLEUM INSTITUTE API RP 581 RISK BASED INSPECTION BASE RESOURCE DOCUMENT BALLOT COVER PAGE

UC A-G Chemistry. Gorman Learning Center (052344) Basic Course Information

Unit 1: Introduction to Biology

Technical Bulletin. Generation Interconnection Procedures. Revisions to Cluster 4, Phase 1 Study Methodology

ChE 471: LECTURE 4 Fall 2003

Subject description processes

Wagon Markings Guidelines

Appropriate Documentation for Phase I and II History/Architecture Reports

For more information about how to cite these materials visit

CHEM 103 Calorimetry and Hess s Law

Science 9 Unit 2: Atoms, Elements and Compounds

Technical Committee Noise. Minutes of the 11 th Meeting

INSTRUMENTAL VARIABLES

5 th grade Common Core Standards

Physics 2B Chapter 23 Notes - Faraday s Law & Inductors Spring 2018

Session #22: Homework Solutions

2004 AP CHEMISTRY FREE-RESPONSE QUESTIONS

Materials o o o o o o o o o

Resampling Methods. Chapter 5. Chapter 5 1 / 52

MACE For Conformation Traits

10 pa. 10 pa. (0) = 2100 ± 200 s -1, z = 0.03 ± The flicker rates fit to: k f

Plant Science Course Outcome Summary Chippewa Valley Technical College

Forensic Science. Group: Background information

colorphlex Chatsworth, CA Anti-breakage Benefits of Hair Care Formulations

Excessive Social Imbalances and the Performance of Welfare States in the EU. Frank Vandenbroucke, Ron Diris and Gerlinde Verbist

Chapter 15 Conjugated Systems

BASD HIGH SCHOOL FORMAL LAB REPORT

UN Committee of Experts on Environmental Accounting New York, June Peter Cosier Wentworth Group of Concerned Scientists.

WRITING THE REPORT. Organizing the report. Title Page. Table of Contents

The Legacy of Ancient Greece

NUROP CONGRESS PAPER CHINESE PINYIN TO CHINESE CHARACTER CONVERSION

I. SEARCH PARAMETERS AND ACCEPTANCE CRITERIA

Effective Date: 10-January Table of Contents

k-nearest Neighbor How to choose k Average of k points more reliable when: Large k: noise in attributes +o o noise in class labels

Testing Groups of Genes

Semester 2 AP Chemistry Unit 12

Introduction to Quantitative Genetics II: Resemblance Between Relatives

A B C. 2. Some genes are not regulated by gene switches. These genes are expressed constantly. What kinds of genes would be expressed constantly?

The standards are taught in the following sequence.

CHM112 Lab Graphing with Excel Grading Rubric

Chapter 6 Fingerprints By the end of this chapter you will be able to:

(2) Even if such a value of k was possible, the neutrons multiply

AP Statistics Notes Unit Two: The Normal Distributions

Misc. ArcMap Stuff Andrew Phay

1 of 11. Adding Signed Numbers. MAT001 Chapter 9 Signed Numbers. Section 9.1. The Number Line. Ordering Numbers. CQ9-01. Replace? with < or >.

Assessment Primer: Writing Instructional Objectives

Group Analysis: Hands-On

Chapter 3 Forensic Laboratory Techniques Cengage Learning. All Rights Reserved

UNIT 6 DETERMINATION OF FLASH AND FIRE POINT OF A LUBRICATING OIL BY OPEN CUP AND CLOSED CUP METHODS

MATCHING TECHNIQUES Technical Track Session VI Céline Ferré The World Bank

Intelligent Pharma- Chemical and Oil & Gas Division Page 1 of 7. Global Business Centre Ave SE, Calgary, AB T2G 0K6, AB.

Chemistry 20 Lesson 11 Electronegativity, Polarity and Shapes

Antibodies and Antigens

Matter Content from State Frameworks and Other State Documents

Transcription:

Altered red bld cell e antigen expressin in variant RHCE*ce alleles. Is it wrth ding a mlecular analysis? Mingmar Sherpa, MLS, SBB (ASCP) cm Mississippi Valley Reginal Bld Center

Objectives Understand the basics f RHCE gene and RhCE prteins. Understand hw a variant RHCE*ce allele can have altered expressin f e antigen. Understand the imprtance f differentiating between an aut anti-e (RH5) versus an all anti-e (RH5) due t partial e expressin. Understand the imprtance f mlecular analysis in prper identificatin f clinically significant antibdy.

Case Study 22 year ld female presented t the ER due t sickle cell crisis. Chief cmplaint Pain lcated in her arms and legs, mre severe in wrists with assciated chills and intermittent dizziness. Patient histry Sickle cell anemia, asthma, and migraines. Patient has n primary r hematlgist

Additinal Histry Transfusin/Pregnancy: N recrd f transfusin r pregnancy at the current hspital. 11/3/2017- transfused 1 unit f prbc at a different facility Febrile transfusin reactin after first unit n 11/3/2017 11/5/2017- transfused 1 unit f prbc (same hspital- previus) Medicatins: Aleve t manage pain 0.9% NaCl infusin Oxycdne and acetaminphen Ondansetrn Mrphine Ketrlac Flic acid

Labs: CBC

Labs: CMP

Labs: Urinalysis

Bld Bank Type and Crss rdered fr transfusin f 1 prbc unit Hspital perfrmed a type and screen pan reactive (including aut cntrl) Sample referred t reference lab

ABO/Rh Anti-A Anti-B Anti-D Rh cntrl A1 cell A2 cell B cell Aut ABO Interp 0 0 4+ NT 4+ NT 4+ NT O psitive 0 0 4+ DAT Result Methd IgG 2+ Gel C3 Neg Tube

Plasma Eluate D C c E e Cw K k Kpb Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lub Gel Gel 1 + + 0 0 + 0 0 + + + + + + + + 0 + 0 + 0 + + 2+ 2 + + 0 0 + + 0 + + + + 0 0 + 0 0 + + + 0 + + 2+ 3 + 0 + + 0 0 0 + + + + + + 0 0 + + + 0 + 0 + 2+ 4 + 0 + 0 + 0 0 + + + 0 + + + 0 + + 0 + + + + 2+ 5 0 + + 0 + + 0 + + + + + + 0 0 + 0 + 0 0 + + 2+ 6 0 0 + + + 0 0 + + + 0 + 0 + 0 + + + 0 0 + + 2+ 7 0 0 + 0 + 0 + + + + 0 + 0 + 0 + 0 + 0 + 0 + 2+ 8 0 0 + 0 + 0 0 + + + + 0 0 + 0 + + + 0 0 + + 2+ 9 0 0 + 0 + 0 0 + + + + + + + 0 + 0 0 + 0 + + 2+ 10 0 0 + 0 + 0 + + + + + + + 0 + 0 + + + + + + 2+ TC + 0 + 0 + 0 0 + + + 0 0 + + 0 0 + 0 + + 0 + 2+ AC 1+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+

Adsrbed Plasma- R1 + + 0 0 + 0 + 0 0 + 0 + + 0 + 0 + D C c E e Cw K k Kpb Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lub Gel 1 + + 0 0 + 0 0 + + + + 0 + 0 + 0 + + 0 + 0 0 2 + + 0 0 + + 0 + + + + 0 0 + 0 0 + + + 0 + + 0 3 + 0 + + 0 0 0 + + + + + + 0 0 + + + 0 + 0 + 0 4 + 0 + 0 + 0 0 + + + 0 + + + 0 + + 0 + + + + 0 5 0 + + 0 + + 0 + + + + + + 0 0 + 0 + 0 0 + + 0 6 0 0 + + + 0 0 + + + 0 + 0 + 0 + + + 0 0 + + 0 7 0 0 + 0 + 0 + + + + 0 + 0 + 0 + 0 + 0 + 0 + 0 8 0 0 + 0 + 0 0 + + + + 0 0 + 0 + + + 0 0 + + 0 9 0 0 + 0 + 0 0 + + + + + + + 0 + 0 0 + 0 + + 0 10 0 0 + 0 + 0 + + + + + + + 0 + 0 + + + + + + 0 TC + 0 + 0 + 0 0 + + + 0 0 + + 0 0 + 0 + + 0 + 0

Adsrbed Plasma- R2 + 0 + + 0 0 + + + + 0 0 + + + 0 + D C c E e Cw K k Kpb Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lub Gel 1 + + 0 0 + 0 0 + + + + 0 + 0 + 0 + + 0 + 0 2+ 2 + + 0 0 + + 0 + + + + 0 0 + 0 0 + + + 0 + + 2+ 3 + 0 + + 0 0 0 + + + + + + 0 0 + + + 0 + 0 + 0 4 + 0 + 0 + 0 0 + + + 0 + + + 0 + + 0 + + + + 2+ 5 0 + + 0 + + 0 + + + + + + 0 0 + 0 + 0 0 + + 2+ 6 0 0 + + + 0 0 + + + 0 + 0 + 0 + + + 0 0 + + 2+ 7 0 0 + 0 + 0 + + + + 0 + 0 + 0 + 0 + 0 + 0 + 2+ 8 0 0 + 0 + 0 0 + + + + 0 0 + 0 + + + 0 0 + + 2+ 9 0 0 + 0 + 0 0 + + + + + + + 0 + 0 0 + 0 + + 2+ 10 0 0 + 0 + 0 + + + + + + + 0 + 0 + + + + + + 2+ TC + 0 + 0 + 0 0 + + + 0 0 + + 0 0 + 0 + + 0 + 2+ sel cell + 0 + + 0 0 + 0 + + + + 0 + 0 + 0 + 0 + + + 0

Adsrbed Plasma- R2 + 0 + + 0 0 + + + + 0 0 + + + 0 + D C c E e Cw K k Kpb Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lub Gel 1 + + 0 0 + 0 0 + + + + 0 + 0 + 0 + + 0 + 0 2+ 2 + + 0 0 + + 0 + + + + 0 0 + 0 0 + + + 0 + + 2+ 3 + 0 + + 0 0 0 + + + + + + 0 0 + + + 0 + 0 + 0 4 + 0 + 0 + 0 0 + + + 0 + + + 0 + + 0 + + + + 2+ 5 0 + + 0 + + 0 + + + + + + 0 0 + 0 + 0 0 + + 2+ 6 0 0 + + + 0 0 + + + 0 + 0 + 0 + + + 0 0 + + 2+ 7 0 0 + 0 + 0 + + + + 0 + 0 + 0 + 0 + 0 + 0 + 2+ 8 0 0 + 0 + 0 0 + + + + 0 0 + 0 + + + 0 0 + + 2+ 9 0 0 + 0 + 0 0 + + + + + + + 0 + 0 0 + 0 + + 2+ 10 0 0 + 0 + 0 + + + + + + + 0 + 0 + + + + + + 2+ TC + 0 + 0 + 0 0 + + + 0 0 + + 0 0 + 0 + + 0 + 2+ sel cell + 0 + + 0 0 + 0 + + + + 0 + 0 + 0 + 0 + + + 0

Adsrbed Plasma- rr 0 0 + 0 + 0 0 + + 0 0 0 + + 0 + 0 D C c E e Cw K k Kpb Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lub Gel 1 + + 0 0 + 0 0 + + + + 0 + 0 + 0 + + 0 + 0 2+ 2 + + 0 0 + + 0 + + + + 0 0 + 0 0 + + + 0 + + 2+ 3 + 0 + + 0 0 0 + + + + + + 0 0 + + + 0 + 0 + 0 4 + 0 + 0 + 0 0 + + + 0 + + + 0 + + 0 + + + + 0 5 0 + + 0 + + 0 + + + + + + 0 0 + 0 + 0 0 + + 1+ 6 0 0 + + + 0 0 + + + 0 + 0 + 0 + + + 0 0 + + 0 7 0 0 + 0 + 0 + + + + 0 + 0 + 0 + 0 + 0 + 0 + 0 8 0 0 + 0 + 0 0 + + + + 0 0 + 0 + + + 0 0 + + 0 9 0 0 + 0 + 0 0 + + + + + + + 0 + 0 0 + 0 + + 0 10 0 0 + 0 + 0 + + + + + + + 0 + 0 + + + + + + 0 TC + 0 + 0 + 0 0 + + + 0 0 + + 0 0 + 0 + + 0 + 0 AC

Adsrbed plasma- rr 0 0 + 0 + 0 0 + + 0 0 0 + + 0 + 0 D C c E e Cw K k Kpb Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lub Gel 1 + + 0 0 + 0 0 + + + + 0 + 0 + 0 + + 0 + 0 2+ 2 + + 0 0 + + 0 + + + + 0 0 + 0 0 + + + 0 + + 2+ 3 + 0 + + 0 0 0 + + + + + + 0 0 + + + 0 + 0 + 0 4 + 0 + 0 + 0 0 + + + 0 + + + 0 + + 0 + + + + 0 5 0 + + 0 + + 0 + + + + + + 0 0 + 0 + 0 0 + + 1+ 6 0 0 + + + 0 0 + + + 0 + 0 + 0 + + + 0 0 + + 0 7 0 0 + 0 + 0 + + + + 0 + 0 + 0 + 0 + 0 + 0 + 0 8 0 0 + 0 + 0 0 + + + + 0 0 + 0 + + + 0 0 + + 0 9 0 0 + 0 + 0 0 + + + + + + + 0 + 0 0 + 0 + + 0 10 0 0 + 0 + 0 + + + + + + + 0 + 0 + + + + + + 0 TC + 0 + 0 + 0 0 + + + 0 0 + + 0 0 + 0 + + 0 + 0 AC

Phentype (with sickle separated cells) C c E e K Fya Fyb Jka Jkb S s 0 4+ 4+ 4+ 0 0 0 3+ 0 0 3+ Hmm e+?? But the patient has anti-e Maybe it s aut anti-e Let s find ut.

Adsrbed Plasma- R2R2 + 0 + + 0 0 + + + + 0 0 + + + 0 + D C c E e Cw K k Kpb Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lub Gel 1 + + 0 0 + 0 0 + + + + 0 + 0 + 0 + + 0 + 0 2+ 2 + + 0 0 + + 0 + + + + 0 0 + 0 0 + + + 0 + + 2+ 3 + 0 + + 0 0 0 + + + + + + 0 0 + + + 0 + 0 + 0 4 + 0 + 0 + 0 0 + + + 0 + + + 0 + + 0 + + + + 2+ 5 0 + + 0 + + 0 + + + + + + 0 0 + 0 + 0 0 + + 2+ 6 0 0 + + + 0 0 + + + 0 + 0 + 0 + + + 0 0 + + 2+ 7 0 0 + 0 + 0 + + + + 0 + 0 + 0 + 0 + 0 + 0 + 2+ 8 0 0 + 0 + 0 0 + + + + 0 0 + 0 + + + 0 0 + + 2+ 9 0 0 + 0 + 0 0 + + + + + + + 0 + 0 0 + 0 + + 2+ 10 0 0 + 0 + 0 + + + + + + + 0 + 0 + + + + + + 2+ TC + 0 + 0 + 0 0 + + + 0 0 + + 0 0 + 0 + + 0 + 2+ AC (tested with sickle separated DAT negative patient cells) 0

Is This e Variant?

HEA Mlecular Patient was referred fr RHCE variant testing

RHCE Gene and RhCE Prteins RH lcus is the mst plymrphic f thse encding the antigens f the 30 BGS antigens in the Rh BGS are the mst immungenic Tw hmlgus genes RHD and RHCE, each spanning 10 exns, encde, respectively, the RhD and RhCE prteins D, C, E, c, and e are the 5 majr Rh antigens encded by these genes

RHCE Gene and RhCE Prteins Alteratin in RHD and RHCE genes due t nucletide changes Cause gene rearrangement May encde altered expressin f antigens, aka partial antigens present technical challenges Mutatins in RHCE result in quantitative and qualitative changes in C/c r E/e antigen expressin, Patient antigen type as C+ and/r e+, but prduce anti-c and/r anti-e. Altered C and e encuntered in African Americans mst frequently.

Gentyping Numerus partial e antigens have been described Several partial e encded by RHCE*ce alleles Many were classified as autantibdies- prir t RH gentyping. Serlgic methds d nt detect variant C r e RH gentyping can identify thse patients wh are at risk fr allimmunizatin if expsed t cnventinal C/c and E/e antigens.

Diagram f sme altered RHD and RHCE alleles cmmn in African Black ethnic grups that cmplicate transfusin in patients with sickle cell disease.

Back t0 ur patient: Gentype Reprt

Hw D I Interpret That?? RHCE*cE/*ce(733G), with a predicted C-c+E+ and e+(partial) phentype, Partial e because f E in trans n the ther allele. Risk fr all anti-c and all anti-e Recmmended phen-matched and e- units C- e- K- Fya- Jkb- S- SDN unit

High-Thrughput Gentyping Mlecular DNA-based genetic methds prvide an invaluable tl fr imprved transfusin therapy fr patients with SCD. Limitatins: Multiple genetic variatins will be fund May, r may nt, be immungenic r affect the phentype. The cmplexity f alleles encding RBC antigens is cmplicated by gegraphy, ppulatin diversity, and ethnicity, and new alleles cntinue t be fund.

What des this all mean? Cmbine the mlecular and serlgical methds t prvide cmpatible bld and t avid additinal allimmunizatin. High-thrughput mlecular methds may be cst-effective when screening large # f dnr units.

References Flegel WA. Mlecular genetics and clinical applicatins fr RH. Transfusin and apheresis science : fficial jurnal f the Wrld Apheresis Assciatin : fficial jurnal f the Eurpean Sciety fr Haemapheresis. 2011;44(1):81-91. di:10.1016/j.transci.2010.12.013. Flegel WA. The genetics f the Rhesus bld grup system. Bld Transfusin. 2007;5(2):50-57. di:10.2450/2007.0011-07. Gaspardi AC, Sippert EA, de Maced MD, Pellegrin J, Csta FF, Castilh L. Clinically relevant RHD-CE gentypes in patients with sickle cell disease and in African Brazilian dnrs. Bld Transfusin. 2016;14(5):449-454. di:10.2450/2016.0275-15. Westhff CM, Vege S, Hipsky CH, et al. RHCE*ceAG(254C>G, Ala85Gly) is prevalent in blacks, encdes a partial ce-phentype, and is assciated with discrdantrhdzygsity. Transfusin. 2015;55(11):2624-2632. di:10.1111/trf.13225. Chu ST, Jacksn T, Vege S, Smith-Whitley K, Friedman DF, Westhff CM. High prevalence f red bld cell allimmunizatin in sickle cell disease despite transfusin frm Rh-matched minrity dnrs. Bld. 2013;122(6):1062-1071. di:10.1182/bld-2013-03-490623.